8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-20-070904
Material agreement · Executive or director change · Shareholder vote results
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading tm2022015d1_8k.htm…